Fri 17 May 2024
Warszawa (PL)
20/10°C
| Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|
| 20 | 21 | 22 | 23 | 25 |
Fri 17 May 2024
Praha (CZ)
13/15°C
| Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|
| 24 | 23 | 17 | 23 | 24 |
Fri 17 May 2024
Bratislava (SK)
15/11°C
| Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|
| 22 | 19 | 17 | 19 | 23 |
Fri 17 May 2024
Budapest (HU)
16/12°C
| Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|
| 23 | 23 | 20 | 24 | 27 |
Czech health ministry allows Japanese drug use for COVID-19
April 17th, 2020
The Czech health ministry has allowed the use of the Japanese drug favipiravir for COVID-19 that will be administered as the anti-flu drug Avigan with the patients' informed consent only as its use is experimental, according to a document that the ministry has released on its website. Other experimental drugs for COVID-19 have already been administered in Czech hospitals, such as remdesivir, developed against Ebola by a team headed by Czech Tomas Cihlar in the US Gilead firm, and medicines containing hydroxychloroquine.
CTK